Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 171 participants.
Also called NCT04870047
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 171 participants
- Sponsor
- Registry
-
NCT04870047
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France, Germany, Israel, Italy, Slovakia, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT04870047. Randomized; no masking; primary purpose treatment. Start 2021-09-03 (actual); primary completion 2024-12-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation
- Acronym
- COATING
- Condition
- Intracranial Aneurysm
- Intervention (Device)
- Endovascular treatment of unruptured aneurysms with p64 MW HPC Flow Modulation Device
- Lead sponsor
- Phenox GmbH
Record details
- Record id
cardio:ct-nct04870047- Content hash
86ecf17c84435eab0c5499b3cabd80b50419f3ea6a72c65a00844b1b6d89546e